======= RGS19 ======= == Gene Information == * **Official Symbol**: RGS19 * **Official Name**: regulator of G protein signaling 19 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10287|10287]] * **UniProt**: [[https://www.uniprot.org/uniprot/P49795|P49795]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RGS19&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RGS19|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605071|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Binds to G-alpha subfamily 1 members, with the order G(i)a3 > G(i)a1 > G(o)a >> G(z)a/G(i)a2. Activity on G(z)-alpha is inhibited by phosphorylation and palmitoylation of the G-protein. |RGS| |G-protein alpha-subunit binding| |brush border| |clathrin-coated vesicle| |response to ethanol| |membrane raft| |response to alcohol| |process utilizing autophagic mechanism| |autophagy| |response to antibiotic| |small GTPase mediated signal transduction| |GTPase activity| |response to toxic substance| |Golgi apparatus| |response to drug| |negative regulation of signal transduction| |G protein-coupled receptor signaling pathway| |negative regulation of cell communication| |negative regulation of signaling| |response to oxygen-containing compound| |negative regulation of response to stimulus| |intracellular signal transduction| |cellular catabolic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|-1.8| |[[:results:exp302|35°C R06 exp302]]|1.71| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|1.71| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|1.9| |[[:results:exp425|Beta-Estradiol 0.55μM R07 exp425]]|2.01| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|2.14| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|2.19| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8852 * **Expression level (log2 read counts)**: 5.3 {{:chemogenomics:nalm6 dist.png?nolink |}}